RYTM did a 120% run in November and December and then pivoted to start the year. It competes in the anti-obesity drug space which is all the rage right now and has snack food manufactures freaking out. The retrace was a shallow one in a sign of strength finding support at the 0.382 retracement level and then pivoting into a reversal in the past week. The dual...
MGNX as a biotech company makes antibodies against certain cancers. The antibody is tagged to chemotherapy molecules and then heads off looking for cancer cells to which it has a strong affinity. So much for the science. MGNX just got upgraded and the new target is $ 16.00 about 25% upside. Biotech and healthcare are projected hot sectors this year. On the...
---MACROGENICS INC--- Weekly Chart Analyse- >>>Price is moviving into a DownChanel...And as u can see it's testing now the Upper Wall of this DownChannel...<<<
MGNX running within a downward channel & now seems reversing from the down channel line. It also seems forming a head & shoulder & now turning upward to form the second shoulder. Both way it looks bullish now. We think it will be a good long from preset price to 24 area. You can check detailed analysis on MGNX in the trading room/ Executive summary link...